Research from Manchester University NHS Foundation Trust Provides New Data on Psoriatic Arthritis (Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy).

A report from Manchester University NHS Foundation Trust discusses the relationship between psoriatic arthritis (PsA) and metabolic syndrome (MetS). PsA is an inflammatory joint and entheseal disease that affects about 20% of people with psoriasis. MetS is frequently associated with PsA and both conditions are characterized by chronic inflammation. The report highlights the prevalence, pathogenesis, prognosis, treatment interactions, and future therapeutic options for MetS in PsA. It suggests that weight loss interventions may reduce disease activity in PsA and recommends further investigation into novel therapies for weight loss as potential adjuncts to disease-modifying therapies for PsA and MetS. [Extracted from the article]